Treatment with anti-ErbB2 antibodies and EGFR-targeted drugs,申请号US20050154465-传众专利搜索

发明名称	Treatment with anti-ErbB2 antibodies and EGFR-targeted drugs
摘要	The present application describes methods for treating cancer with anti-ErbB2 antibodies, such as humanized anti-ErbB2 antibodies, and EGFR-targeted drugs.
申请公布号	US2005238640(A1)	申请公布日期	2005.10.27
申请号	US20050154465	申请日期	2005.06.16
申请人	GENENTECH, INC.	发明人	SLIWKOWSKI MARK
分类号	A61K47/48;C07K16/32;(IPC1-7):A61K39/395	主分类号	A61K47/48
代理机构		代理人
主权项
地址